6 Drugs Whose Dangerous Risks Were Buried So Big Pharma Could Make Money

(ALTERNET)   When a prescription drug causes risky side effects, the word often doesn’t get out for years, allowing Big Pharma to make money anyway.

The FDA and Big Pharma contend that dangerous side-effects in a prescription drug only emerge when it is used by millions instead of the relatively small group of people in clinical trials. But there is another reason the public ends up guinea pigs. Prescription drugs are rushed to market in as little as six months so industry can start making money while safety is still being determined. Both Merck’s risk-laden bone drug Fosamax and painkiller Vioxx were on the market after a six-month review. In the case of Vioxx, it was because “the drug potentially provided a significant therapeutic advantage over existing approved drugs,” the FDA said.

Thanks for that. And five drugs (Trovan, Rezulin, Posicor, Duract and Meridia) rushed through in 1997 because of Pharma and congressional pressure on the FDA, says Public Citizen, were subsequently withdrawn.

Here are some drugs whose risks did not did not keep them from getting their “patent’s worth.”

READ THE FULL LIST OF MEDICATIONS HERE

Leave a Reply

Your email address will not be published. Required fields are marked *

Show some support!

We are 100% Listener & User supported!! Every little bit helps us continue. Donations help fund the site and keep all the free information on it. Thanks in advance and KEEP UP THE FIGHT!!!

News Categories
Col. L Fletcher Prouty: Secret Team
FEDERALJACK'S TWITTER POPEYE'S TWITTER